Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

The week so far: stocks stay in positive territory, Mesoblast surges

We take a look at some of the key market moves from Monday to Thursday.

ASX 200 Source: Bloomberg

ASX 200: a tale of two halves

Australia 200 shares have slipped from mid-week highs but are still in positive territory overall.

The benchmark ASX 200 index finished Thursday’s session at 5,364.20 points, up 44.4 points, or 0.8% for the week.

So far, the week has been a tale of two halves. On Tuesday, the index closed at 5,407.10 points, up 161.20 points, or 3.1% for the first two sessions of the week. The result was driven predominantly by banks and energy shares, with materials only slightly up and healthcare down.

By Thursday’s close, the roles had changed. The ASX 200 Financials index slipped into negative territory, down 0.5% for the week.

Healthcare on the other hand turned positive, up 0.5%, while energy shares were off their Tuesday highs, but still up 3.3%. Materials also helped out on the mining heavy ASX 200, rising from modest gains on Tuesday to be up 2.8% with one day left in the week.

Healthcare and Energy stocks in focus

As the index started to come off its midweek highs the news turned towards healthcare companies, which are thought of by many as counter-cyclical and useful during an economic downturn.

Blood plasma giant CSL Ltd (CSL) finished Thursday’s session at $307.93, down 1.9% for the week. The company conducted a US$750 million debt raising ‘for general corporate purposes.’

Elsewhere in the sector things were looking positive. Bionic-ear maker Cochlear Ltd (COH) rose 2.9% to $184.50, while Sonic Healthcare Ltd (SHL) jumped 5.6% for the week so far to last trade at $25.86.

But all eyes were on regenerative medicine company Mesoblast (MSB), which surged by 12.5% on Wednesday after news broke that it had started phase 2/3 of a trial treating 300 patients in the US with severe Covid-19 symptoms. The company’s shares are up 9.6% for the week to $3.54.

While Mesoblast isn’t in the ASX 200 for the moment, some have speculated that it could soon be. The company’s share price has shot up from $1.11 on 23 March and its market capitalisation of $1.8 billion is higher than a number of companies currently included in the ASX 200 index.

Energy shares also came off a shade, though still remained elevated, as oil prices eased from a strong rally.

Woodside Petroleum Ltd (WPL) shares were still up 6.4% for the week so far – from Monday to Thursday – to $21.65, rival Santos Ltd (STO) leapt 9.7% to $4.76, Oil Search Ltd (OSH) jumped 10% per cent to $2.87. Meanwhile, Origin Energy Ltd surged 14.3% $5.53 and AGL Energy Ltd lost 4.2% to end at $16.39.

Petrol company Ampol Limited (CTX) said the crude oil market has weakened significantly. Tanker storage had increased, which pushed up freight rates. Adding to that, demand for jet fuel and petrol have fallen hard.

Even so, Caltex shares were still up 8.5% for the week to $24.34.

In economic news, Australia booked a record trade surplus of $10.6 billion in March, while retail spending rose by a record 8.5 per cent thanks to the panic buying that ensued in the wake of Covid-19.

How to trade indices: long and short

What do you make of the current situation: do you see bullish or bearish opportunities? Whatever your opinion, you can trade indices, currencies and equities – both LONG or SHORT – with IG’s world-class trading platform now.

For example, to buy (long) or sell (short) the ASX 200 index using CFDs, follow these easy steps:

  • Create an IG Trading Account or log in to your existing account
  • Enter ‘Australia 200’ in the search bar and select it
  • Choose your position size
  • Click on ‘buy’ or ‘sell’ in the deal ticket
  • Confirm the trade

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.